TELIX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.netwww.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHSun, 28 Jun 2026 08:12:45 +0200https://images.finanzen.net/images/finanzen_net_neu.gifTELIX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.nethttps://www.finanzen.netTelix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare ConferenceThu, 08 Jan 2026 12:00:00 +0100https://www.finanzen.net/nachricht/aktien/telix-to-present-pipeline-and-commercial-portfolio-overview-at-j-p-morgan-healthcare-conference-15401671

MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals ...

]]>https://www.finanzen.net/nachricht/aktien/telix-to-present-pipeline-and-commercial-portfolio-overview-at-j-p-morgan-healthcare-conference-15401671DEADLINE ALERT for FUN, TLX, LRN, PRMB: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class ActionsMon, 05 Jan 2026 21:35:00 +0100https://www.finanzen.net/nachricht/aktien/deadline-alert-for-fun-tlx-lrn-prmb-law-offices-of-howard-g-smith-reminds-shareholders-of-opportunity-to-lead-securities-fraud-class-actions-15393473

BENSALEM, Pa., Jan. 5, 2026 /PRNewswire/ -- Law Offices of Howard G. Smith reminds ...

]]>https://www.finanzen.net/nachricht/aktien/deadline-alert-for-fun-tlx-lrn-prmb-law-offices-of-howard-g-smith-reminds-shareholders-of-opportunity-to-lead-securities-fraud-class-actions-15393473TELIX PHARMACEUTICALS (NASDAQ: TLX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 9, 2026Mon, 05 Jan 2026 14:36:00 +0100https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-nasdaq-tlx-class-action-deadline-approaching-berger-montague-advises-investors-to-inquire-about-a-securities-fraud-class-action-by-january-9-2026-15392394

PHILADELPHIA, Jan. 5, 2026 /PRNewswire/ -- National plaintiffs' law firm https://www.finanzen.net/nachricht/aktien/telix-pharmaceuticals-nasdaq-tlx-class-action-deadline-approaching-berger-montague-advises-investors-to-inquire-about-a-securities-fraud-class-action-by-january-9-2026-15392394